Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

Details for Australian Patent Application No. 2010212374 (hide)

Owner The Government of the United States of America, as represented by the Secretary of Health and Human Services Novavax, Inc.

Inventors Emerson, Suzanne U.; Purcell, Robert H.; Tsarev, Sergi A.; Robinson, Robin A.

Agent Griffith Hack

Pub. Number AU-A-2010212374

Filing date 16 August 2010

Wipo publication date 2 September 2010

International Classifications

C07K 14/08 (2006.01) Peptides having more than 20 amino acids

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/51 (2006.01) Mutation or genetic engineering - Hepatitis viruses

G01N 33/576 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for hepatitis

Event Publications

2 September 2010 Application Open to Public Inspection

  Published as AU-A-2010212374

2 September 2010 Complete Application Filed

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212375-Stabilized anti-respiratory syncytial virus (RSV) antibody formulations

2010212373-Methods and Apparatus to Classify Text Communications